Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG in Rectal Cancer Lymph Node Dissection
NCT05517681Completed
- Sponsor
- The First Hospital of Qinhuangdao
- Start
- Sep 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of indocyanine green in rectal cancer (2 arms), sponsored by The First Hospital of Qinhuangdao. Primary endpoints: The number of cleared IMA root lymph nodes, The total number of cleared lymph nodes and 1 more. Started Sep 2020; status: completed.
02
Drugs
indocyanine green
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05517681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517681.